Correlation Between Cyxone AB and Sprint Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyxone AB and Sprint Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyxone AB and Sprint Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyxone AB and Sprint Bioscience AB, you can compare the effects of market volatilities on Cyxone AB and Sprint Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyxone AB with a short position of Sprint Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyxone AB and Sprint Bioscience.

Diversification Opportunities for Cyxone AB and Sprint Bioscience

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cyxone and Sprint is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cyxone AB and Sprint Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sprint Bioscience and Cyxone AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyxone AB are associated (or correlated) with Sprint Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sprint Bioscience has no effect on the direction of Cyxone AB i.e., Cyxone AB and Sprint Bioscience go up and down completely randomly.

Pair Corralation between Cyxone AB and Sprint Bioscience

Assuming the 90 days trading horizon Cyxone AB is expected to under-perform the Sprint Bioscience. In addition to that, Cyxone AB is 2.81 times more volatile than Sprint Bioscience AB. It trades about -0.04 of its total potential returns per unit of risk. Sprint Bioscience AB is currently generating about 0.08 per unit of volatility. If you would invest  130.00  in Sprint Bioscience AB on September 3, 2024 and sell it today you would earn a total of  52.00  from holding Sprint Bioscience AB or generate 40.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cyxone AB  vs.  Sprint Bioscience AB

 Performance 
       Timeline  
Cyxone AB 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cyxone AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Cyxone AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
Sprint Bioscience 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sprint Bioscience AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Sprint Bioscience sustained solid returns over the last few months and may actually be approaching a breakup point.

Cyxone AB and Sprint Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyxone AB and Sprint Bioscience

The main advantage of trading using opposite Cyxone AB and Sprint Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyxone AB position performs unexpectedly, Sprint Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sprint Bioscience will offset losses from the drop in Sprint Bioscience's long position.
The idea behind Cyxone AB and Sprint Bioscience AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges